Poseida Therapeutics Inc. Gains 227.97%

Tue, Nov 26, 2024 at 07:46 PM

Poseida Therapeutics Inc. (PSTX:NASDAQ) rocketted at $9.38, a gain of 228%. On Tue, Nov 26, 2024, PSTX:NASDAQ hit a New 2-Week High of $9.38. The stock got featured on our News Catalysts scanner on Tue, Nov 26, 2024 at 01:49 PM in the 'ACQUISITION' category. From Tue, Nov 12, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days

About Poseida Therapeutics Inc. (PSTX:NASDAQ)

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet...

Top 10 Gainers:

Primega Group Holdings Limited (PGHL:NASDAQ), 918.6%
Poseida Therapeutics Inc. (PSTX:NASDAQ), 227.97%
SRAX, Inc. (SRAX:NASDAQ), 157%
CIMG Inc Com Par $0.00001 (IMG:NASDAQ), 153.97%
TOYO Co. Ltd (TOYO:NASDAQ), 81.54%
Palladyne AI Corp. (PDYN:NASDAQ), 63.49%
Ocean Power Technologies Inc. (OPTT:NYSEMKT), 63.07%
ZenaTech Inc. (ZENA:NASDAQ), 60.44%
Hesai Group (HSAI:NASDAQ), 44.42%
DevvStream Corp. (DEVS:NASDAQ), 40.64%